Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reply to Decroo et al.: High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis

Kelly E Dooley1, Sachiko Miyahara2, Florian von Groote-Bidlingmaier3,4

  • 1Johns Hopkins University School of MedicineBaltimore, Maryland.

American Journal of Respiratory and Critical Care Medicine
|March 5, 2020
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of a 4-month quabodepistat, delamanid, and bedaquiline regimen for drug-susceptible pulmonary tuberculosis: a multicentre, open-label, randomised, proof-of-concept, non-inferiority, phase 2b/c trial.

The Lancet. Infectious diseases·2026
Same author

KEAP1-mediated mitochondrial remodeling on stiffness-graded collagen substrates drives hepatocellular carcinoma adaptation.

Biomaterials·2026
Same author

Second-Generation Anti-Tubercular Squaramides Targeting Complex V of the Respiratory Chain of <i>Mycobacterium tuberculosis</i> Displaying Enhanced Metabolic Stability.

Journal of medicinal chemistry·2026
Same author

A 48-week, Randomized Controlled Trial of Doravirine for Individuals with HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391).

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Host-directed treatments for tuberculous meningitis: A multi-platform approach across mouse and human models.

Research square·2026
Same author

Exposure-QTc modeling of bedaquiline, pretomanid, and clofazimine in adults with tuberculosis.

Antimicrobial agents and chemotherapy·2026